Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DN Company is a leading medical aesthetics and pharmaceutical company based in South Korea and a key affiliate of the Daewoong Group. Established in 2001, the company specializes in providing total solutions for the dermatology and plastic surgery markets, encompassing botulinum toxins, dermal fillers, and cosmeceuticals. Its flagship portfolio includes NABOTA (botulinum toxin type A), various hyaluronic acid fillers like Cleviel and Giselleligne, and products utilizing DW-EGF (recombinant human epidermal growth factor). DN Company is instrumental in the commercialization and distribution of Daewoong's aesthetic innovations globally, focusing on high-performance skin-healing and anti-aging treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DN Company.